Moderna completes enrollment in Phase II Covid-19 vaccine trial July 9, 2020 Auto Bot BioPharma, biopharma nl, Cambridge, Massachusetts, Moderna, mRNA-1273, SARS-CoV-2 0 The company said it is on track to start its 30,000-participant Phase III trial this month and has finished manufacturing enough supplies of the vaccine to do so.